Table 2 Treatment details (n = 90)
Radiation dose (Gy) | ||
 Median (range) | 50.4 (50.4–66.6) |  |
Radiation field | ||
 Bilateral | 65 (72%) |  |
 Bilateral + boost | 19 (21%) |  |
 Unilateral | 5 (6%) |  |
 Unilateral + boost | 1 (1%) |  |
Boost irradiation | ||
 Yes | 20 (22%) |  |
 No | 70 (78%) |  |
Concurrent chemotherapy | ||
 Yes | 68 (76%) |  |
 No | 22 (24%) |  |
Chemotherapy regimen | ||
 CDGP + 5FU | 32 (47%) |  |
 CDDP | 13 (19%) |  |
 CDDP + 5FU | 9 (13%) |  |
 CDGP + DTX | 6 (9%) |  |
 DTX | 5 (7%) |  |
 CBDCA | 2 (3%) |  |
 CDDP + DTX | 1 (2%) |  |